Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...

Teleflex (TFX) has drawn attention after a mixed stretch, with the stock up about 1.5% in the past day but showing weaker returns over the past week, month, and past 3 months. See our latest analysis ...

Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021. TFX stock was trading at around $246 in early ...

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.

Investing.com - Needham upgraded Teleflex (NYSE:TFX) from Hold to Buy and set a price target of $138.00 on Tuesday. The target represents significant upside potential, as InvestingPro data shows the ...

The stock price of Teleflex, best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down over 4% ...

Investing.com - Needham raised its price target on Teleflex Inc. shares (NYSE:TFX) to $147 from $138 while maintaining a Buy rating on the stock. The shares currently trade at $119.63, and ...